Executive Team & Bios

Dr. Gil Price
CEO and Chief Medical Officer

Dr. Gil Price is a clinical physician trained in Internal medicine with a long-standing interest in the study of adverse drug reactions, drug utilization, drug development and regulation. He is an accomplished senior level manager with over 18 years of diverse therapeutic drug development experience. His responsibilities have included pharmacovigilance, competitive intelligence, and clinical development. Prior to his current position as CEO of Drug Safety Solutions, Dr. Price was the Director of Clinical Development for Oncology at MedImmune Inc. He previously worked in the CRO sector at ClinTrials. Dr. Price began his pharmaceutical career at Glaxo Inc. in Research Triangle Park, NC, where he worked for nearly nine years on both the commercial and research sides of the company.

Dr. Price is a member of the American Medical Association the Academy of Pharmaceutical Physicians and the American Society of Microbiology.

Dr. Katherine Smith
Senior Medical Officer

Dr. Katherine Smith, a board certified pediatrician with fourteen years of clinical pediatric experience, has a keen awareness of the evolving application of pharmaceutical products in the pediatric population. She continues to practice clinical medicine in conjunction with her work in drug safety. As a medical officer for Drug Safety Solutions since 2002, Dr. Smith’s responsibilities include protocol review and serious adverse event (SAE) management. Dr. Smith is also a scientific board member of the independent institutional review board, Copernicus Group IRB. Her role at the CGIRB has sharpened her skills in critical protocol and informed consent review, and given her insight into drug safety from the subject and regulatory perspectives.

Dr. Mark Sorrentino
Medical Officer

Dr. Mark Sorrentino is a practicing Pediatric Critical Care physician with over a decade of clinical research, safety, and post-marketing experience. He has overseen large clinical projects, including patient registries with more than 5,000 subjects. Dr. Sorrentino is the founder and Chief Medical Officer of HAS Physicians, a healthcare consulting agency with clinical development expertise, and was formerly a Medical Science Director at MedImmune, Inc., where he focused on anti-viral studies for neonates and transplant patients.

Dr. Sorrentino is an Assistant Clinical Professor at the George Washington School of Medicine, and a member of the Society of Critical Care Medicine, American Academy of Pediatrics, American College of Physician Executives, and the AMA.

Kristen Eagle, R.N.
Drug Safety Consultant

Ms. Kristen Eagle is a registered nurse with a clinical background in intensive care, pre-operative, and oncology nursing. She has worked as a drug safety consultant for Drug Safety Solutions since 2002, managing the safety reporting for several oncology studies. She was previously employed in the clinical trial industry as an oncology site study coordinator, where she participated in all aspects of clinical trial management including enrollment, informed consent, and safety and data management. She subsequently functioned as a product safety associate for Inveresk Research in Research Triangle Park, NC, where she managed the safety reporting for several large oncology and asthma studies and was promoted to senior safety associate.

Ms. Eagle is licensed with the North Carolina Board of Nursing.

Kim Beckett
COO and Senior Drug Safety Consultant

Ms. Kim Beckett is a board-certified medical technologist with an additional degree in chemistry. Since 1994, she has trained and worked in safety management with pharmaceutical companies and contract research organizations. In 1998, she became Drug Safety Solutions’ chief operating officer and senior drug safety consultant. In this position, she is responsible for managing daily AE/SAE activities, coding services, overseeing medical review of case report forms, generating queries, coordinating services requiring physician interaction, preparing proposals, managing marketing materials, and maintaining the company’s standard operating procedures. Prior to her current position, Ms. Beckett had supervisory involvement in SAE management at ClinTrials Research, where she worked with a wide variety of pharmaceutical companies and clinical trials.